Furthermore, analysis of the gene expression data from the human brain tumor immune microenvironment (26) demonstrated the highest CD109 expression in the monocyte-derived macrophages, yet the expression did not increase in glioblastomas compared with the nontumor reference samples (Supplemental Figure 1D). This evidence concerns the gene CD109 and glioblastoma.